COVID-19 백신 분배 윤리
The Ethics of COVID-19 Vaccine Allocation
0
조회
0
다운로드
6
인용
0
참고문헌
키워드
초록
과거 사스, 인플루엔자, 메르스 등 전염병은 부분적으로 사회를 마비시켰지만 이번 COVID-19는 그보다 더 광범위한 영향을 미치고 있다. 격리, 검역, 국경 통제, 사회적 거리두기 등 방역 조치는 단기적으로 질병이 확산하지 않도록 할 수 있으나 장기적인 해결책은 아니다. 백신을 통한 집단면역 형성만이 COVID-19 사태를 종식시킬 수 있다. COVID-19에 대한 백신은 집단면역을 구축하기 위해 광범위하게 배치되어야 한다. 효과적인 COVID-19 백신은 희귀한 자원으로서 백신을 공정하게 배포하는 방법에 대한 윤리적 문제가 제기된다. 백신 분배에 있어서 이익을 극대화하고 불평등과 불균형을 완화해야 한다. 형평성, 투명성, 공정성을 통해 이익 극대화를 장려해야 한다. 백신 우선순위 지정 전략에 대한 명확하고 투명한 기준을 제공해야 한다. 백신과 같은 부족한 의료자원을 분배하는 것은 장기적이고 지속적인 윤리적 과제다. 윤리적으로 잘 조정된 백신 분배 계획만이 도움이 필요한 모든 사람이 백신에 공정하게 접근할 수 있으며 COVID-19뿐만 아니라 미래 전염병 발생 시 부족한 의료자원의 공정한 분배에서 윤리적으로 대응할 수 있다.
Abstract
Border controls and social distancing have proven effective in containing the spread of COVID-19, but the current pandemic will not end until herd immunity is achieved through the widespread use of vaccines. Given the importance of vaccines in overcoming this global health crisis, and the current imbalance between their supply and demand, ethical questions arise concerning how COVID-19 vaccines should be distributed. This article argues that the guiding objectives for the distribution of COVID-19 vaccines should be the reduction of inequality and the maximization of benefits through the use of clear and transparent criteria for vaccine prioritization. Allocating scarce medical resources such as vaccines is a long-term ethical challenge. Only an ethically sound and well-coordinated vaccine distribution plan can ensure fair access for those in need.
참고문헌 (45)
- "COVID-19 Dashboard by the Center for Systems Science and Engineering(CSSE) at Johns Hopkins University(JHU)"[URL]
- Yangzi Liu, "Multivalue ethical framework for fair global allocation of a COVID-19 vaccine", J Med Ethics, (46), pp.499~501 (2020)
- "Pfizer-BioNTech COVID-19 Vaccine" (2020)[URL]
- "Moderna COVID-19 Vaccine" (2020)[URL]
- "The Advisory Committee on Immunization Practices’ Updated Interim Recommendation for Allocation of COVID-19 Vaccine-United States, December 2020" (2020)[URL]
- Williamson EJ, "Factors associated with COVID-19-related death using Open SAFELY", Nature, 584(7821), pp.430~436 (2020)
- "Joint Committee on Vaccination and Immunisation: advice on priority groups for COVID-19 vaccination, 30 December 2020" (2020)[URL]
- "Evidence Table for COVID-19 Vaccines Allocation in Phases 1b and 1c of the Vaccination Program" (2020)[URL]
- Helene Gayle, "Framework for Equitable Allocation of COVID-19Vaccine" (2020), The National Academies Press
- "Evidence Table for COVID-19 Vaccines Allocation in Phases 1b and 1c of the Vaccination Program" (2020)[URL]
- McGough LJ, "Which patients first? Setting priorities for antiretroviral therapy where resources are limited", Am J Pub Health, (95), pp.1173~1180 (2005)
- "건복지부 신종 인플루엔자 대유행 대비.대응계획" (2006)[URL]
- "의료계-정부 , 코로나1 9 백신 의정공동위원회 1차회의 개최" (2021)[URL]
- "코로나19 백신 및 예방접종 1분기 접종계획" (2021)[URL]
- "화이자백신도 접종 시작 … 1 호 접종자는 코로나 19병동 미화원" (2021)[URL]
- "국내 첫 코로나 백신 접종 현장…" (2021)[URL]
- C. -E. A. Winslow, "The Untilled Fileds of Publich health", Science, 51(1306), pp.23~33 (1920)
- Drue H. Barrett, "Public Health Ethics: Cases Spanning the Globe" (2016), Springer Open
- Holland, Stephen, "Public health ethics" (2015), Polity Press
- Norman Daniels etc, "The Role of Costeffectiveness Analysis in Health and Medicine", JAMA, 276(14), pp.1172~1177 (1996)[DOI]
- Drue H. Barrett, "Public Health Ethics: Cases Spanning the Globe", pp.62~ (2016), Springer Open
- Drue H. Barrett, "Public Health Ethics: Cases Spanning the Globe", pp.63~ (2016), Springer Open
- Daniel Normans, "Rationing Fairly: Programmatic Considerations", Bioethics, 7(2-3), pp.224~233 (1993)[DOI]
- "Guidance for Managing Ethical Issues in Infectious Disease Outbreaks 2016" (2016)[URL]
- "Addressing ethical issues in pandemic influenza planning DISCUSSION PAPERS 2008" (2008)[URL]
- Emanuel EJ, "Fair allocation of scarce medical resources in the time of COVID-19", The New England Journal of Medicine, 382, pp.2049~2055 (2020)
- "Interim Framework for COVID-19 Vaccine Allocation and Distribution in the United States" (2020)[URL]
- "WHO SAGE values framework for the allocation and prioritization of COVID-19vaccination" (2020)[URL]
- "The Advisory Committee on Immunization Practices’ Ethical Principles for Allocating Initial Supplies of COVID-19 Vaccine — United States, 2020" (2020)[URL]
- "Annex A: COVID-19 vaccine and health inequalities: considerations for prioritisation and implementation" (2020)[URL]
- Persad G, "Principles for allocation of scarce medical interventions", Lancet, 373(9661), pp.423~431 (2009)
- Stephen Palmer, "Definitions of efficiency", BMJ, 318(7191), pp.1136~ (1999)
- Hsieh N-H, "The numbers problem", Philos Publ Aff, (34), pp.352~372 (2006)
- McKie J, "Neglected equity issues in cost-eff ectiveness analysis, Part 1:severity of pre-treatment condition, realisation of potential for health, concentration and dispersion of health benefits, and age-related social preferences" (2009), Centre for Health Program Evaluation
- Govind Persad, "Principles for allocation of scarce medical interventions", Lancet, (373), pp.423~431 (2009)
- "Ventilator allocation guidelines" (2015)[URL]
- "Framework for Equitable Allocation of COVID-19 Vaccine" (2020)[URL]
- Angus Dawson, "Key Ethical Concepts and Their Application to COVID-19 Research", Public Health Ethics, 13(2), pp.127~132 (2020)
- W-C Chang, "The meaning and goals of equity in health", J Epidemiol Community Health, 56(7), pp.488~491 (2002)
- "Fair and equitable access to COVID-19 treatments and vaccines" (2020)[URL]
- "Joint Committee on Vaccination and Immunisation: advice on priority groups for COVID-19 vaccination, 30 December 2020" (2020)[URL]
- "A Basic Demographic Profile of Workers in Frontline Industries" (2020)[URL]
- "世卫组织公平获取和公正分配 COVID-19卫生产品的概念"[URL]
- Snowden, F. M., "Epidemics and society: From the black death to the present" (2019), Yale University Press
- 김도균, "한국 사회에서 정의란 무엇인가: 우리 헌법에 담긴 정의와 공정의 문법" (2020), 아카넷